These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8230099)

  • 1. Synthesis and structure-activity relationships of a series of penicillin-derived HIV proteinase inhibitors containing a stereochemically unique peptide isostere.
    Holmes DS; Bethell RC; Cammack N; Clemens IR; Kitchin J; McMeekin P; Mo CL; Orr DC; Patel B; Paternoster IL
    J Med Chem; 1993 Oct; 36(21):3129-36. PubMed ID: 8230099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A series of penicillin-derived C2-symmetric inhibitors of HIV-1 proteinase: structural and modeling studies.
    Wonacott A; Cooke R; Hayes FR; Hann MM; Jhoti H; McMeekin P; Mistry A; Murray-Rust P; Singh OM; Weir MP
    J Med Chem; 1993 Oct; 36(21):3113-9. PubMed ID: 8230097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A series of penicillin derived C2-symmetric inhibitors of HIV-1 proteinase: synthesis, mode of interaction, and structure-activity relationships.
    Humber DC; Bamford MJ; Bethell RC; Cammack N; Cobley K; Evans DN; Gray NM; Hann MM; Orr DC; Saunders J
    J Med Chem; 1993 Oct; 36(21):3120-8. PubMed ID: 8230098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of a series of penicillin-derived HIV proteinase inhibitors: heterocyclic ring systems containing P1' and P2' substituents.
    Kitchin J; Bethell RC; Cammack N; Dolan S; Evans DN; Holman S; Holmes DS; McMeekin P; Mo CL; Nieland N
    J Med Chem; 1994 Oct; 37(22):3707-16. PubMed ID: 7966131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of HIV-1 proteinase containing 2-heterosubstituted 4-amino-3-hydroxy-5-phenylpentanoic acid: synthesis, enzyme inhibition, and antiviral activity.
    Scholz D; Billich A; Charpiot B; Ettmayer P; Lehr P; Rosenwirth B; Schreiner E; Gstach H
    J Med Chem; 1994 Sep; 37(19):3079-89. PubMed ID: 7932531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptidic potent HIV-1 protease inhibitors: (4-hydroxy-6-phenyl-2-oxo-2H- pyran-3-yl)thiomethanes that span P1-P2' subsites in a unique mode of active site binding.
    Prasad JV; Para KS; Tummino PJ; Ferguson D; McQuade TJ; Lunney EA; Rapundalo ST; Batley BL; Hingorani G; Domagala JM
    J Med Chem; 1995 Mar; 38(6):898-905. PubMed ID: 7699705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of the protease from human immunodeficiency virus: synthesis, enzyme inhibition, and antiviral activity of a series of compounds containing the dihydroxyethylene transition-state isostere.
    Thaisrivongs S; Turner SR; Strohbach JW; TenBrink RE; Tarpley WG; McQuade TJ; Heinrikson RL; Tomasselli AG; Hui JO; Howe WJ
    J Med Chem; 1993 Apr; 36(8):941-52. PubMed ID: 8478908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine.
    Mimoto T; Kato R; Takaku H; Nojima S; Terashima K; Misawa S; Fukazawa T; Ueno T; Sato H; Shintani M; Kiso Y; Hayashi H
    J Med Chem; 1999 May; 42(10):1789-802. PubMed ID: 10346931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity.
    Tucker TJ; Lumma WC; Payne LS; Wai JM; de Solms SJ; Giuliani EA; Darke PL; Heimbach JC; Zugay JA; Schleif WA
    J Med Chem; 1992 Jul; 35(14):2525-33. PubMed ID: 1635054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere.
    Kiso Y
    Biopolymers; 1996; 40(2):235-44. PubMed ID: 8785365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostere.
    Getman DP; DeCrescenzo GA; Heintz RM; Reed KL; Talley JJ; Bryant ML; Clare M; Houseman KA; Marr JJ; Mueller RA
    J Med Chem; 1993 Jan; 36(2):288-91. PubMed ID: 8423599
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination of non-natural D-amino acid derivatives and allophenylnorstatine-dimethylthioproline scaffold in HIV protease inhibitors have high efficacy in mutant HIV.
    Nakatani S; Hidaka K; Ami E; Nakahara K; Sato A; Nguyen JT; Hamada Y; Hori Y; Ohnishi N; Nagai A; Kimura T; Hayashi Y; Kiso Y
    J Med Chem; 2008 May; 51(10):2992-3004. PubMed ID: 18426195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitors.
    Thaisrivongs S; Janakiraman MN; Chong KT; Tomich PK; Dolak LA; Turner SR; Strohbach JW; Lynn JC; Horng MM; Hinshaw RR; Watenpaugh KD
    J Med Chem; 1996 Jun; 39(12):2400-10. PubMed ID: 8691434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and analysis of a series of C2-symmetric HIV-1 proteinase inhibitors derived from penicillin.
    Gray NM; Cameron JM; Cammack N; Cobley KN; Holmes DS; Humber DC; Orr DC; Penn CR; Potter R; Madar S
    Anal Biochem; 1994 Jan; 216(1):89-96. PubMed ID: 8135370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity studies of FIV and HIV protease inhibitors containing allophenylnorstatine.
    Le VD; Mak CC; Lin YC; Elder JH; Wong CH
    Bioorg Med Chem; 2001 May; 9(5):1185-95. PubMed ID: 11377177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design, synthesis, and crystallographic analysis of a hydroxyethylene-based HIV-1 protease inhibitor containing a heterocyclic P1'--P2' amide bond isostere.
    Thompson SK; Murthy KH; Zhao B; Winborne E; Green DW; Fisher SM; DesJarlais RL; Tomaszek TA; Meek TD; Gleason JG
    J Med Chem; 1994 Sep; 37(19):3100-7. PubMed ID: 7932533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: modifications of the P1/P1' residues.
    Patel M; Bacheler LT; Rayner MM; Cordova BC; Klabe RM; Erickson-Viitanen S; Seitz SP
    Bioorg Med Chem Lett; 1998 Apr; 8(7):823-8. PubMed ID: 9871548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 protease inhibitors with a transition-state mimic comprising a tertiary alcohol: improved antiviral activity in cells.
    Mahalingam AK; Axelsson L; Ekegren JK; Wannberg J; Kihlström J; Unge T; Wallberg H; Samuelsson B; Larhed M; Hallberg A
    J Med Chem; 2010 Jan; 53(2):607-15. PubMed ID: 19961222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of the protease from human immunodeficiency virus: design and modeling of a compound containing a dihydroxyethylene isostere insert with high binding affinity and effective antiviral activity.
    Thaisrivongs S; Tomasselli AG; Moon JB; Hui J; McQuade TJ; Turner SR; Strohbach JW; Howe WJ; Tarpley WG; Heinrikson RL
    J Med Chem; 1991 Aug; 34(8):2344-56. PubMed ID: 1875334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.